Phenobarbital Tablet
NDC Package 64950-577-10
Package Information
Phenobarbital tablets is a medication used alone or with other medications to control seizures. This formulation utilizes a tablet delivery system. Marketed by Genus Lifesciences, this product is identified by NDC 64950-577.
Identification & Billing
- RxCUI: 198083 - PHENobarbital 100 MG Oral Tablet
- RxCUI: 198083 - phenobarbital 100 MG Oral Tablet
- RxCUI: 198086 - PHENobarbital 16.2 MG Oral Tablet
- RxCUI: 198086 - phenobarbital 16.2 MG Oral Tablet
- RxCUI: 198089 - PHENobarbital 60 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64950 - Genus Lifesciences
- 64950-577 - Phenobarbital
- 64950-577-10 - 1000 TABLET in 1 BOTTLE
- 64950-577 - Phenobarbital
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (64950-577). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64950-577-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Phenobarbital, a human prescription drug labeled by Genus Lifesciences. This product is billed for "EA" each discreet unit and contains an estimated amount of 1000 billable units per package. This tablet is formulated for oral use and contains phenobarbital as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genus Lifesciences on March 01, 2025. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Phenobarbital belongs to a class of drugs known as barbiturate anticonvulsants/hypnotics. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure. This medication is also used for a short time (usually no more than 2 weeks) to help calm you or help you sleep during periods of anxiety. It works by affecting certain parts of the brain to cause calming.
How is this Genus Lifesciences product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64950057710. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.